Toxoplasma gondii (T. gondii) is a global protozoan parasite infecting up to one-third of the
world population. Pyrimethamine (PYR) and sulfadiazine (SDZ) are the most widely used …

The protozoan Toxoplasma gondii, an obligate intracellular parasite, is an etiological agent
of human and animal toxoplasmosis. Treatment regimens for T. gondii-infected patients …

Toxoplasmosis is a prevalent disease affecting a wide range of hosts including
approximately one-third of the human population. It is caused by the sporozoan parasite …

Toxoplasmosis is a parasitic disease caused by the globally distributed protozoan parasite
Toxoplasma gondii, which infects around one-third of the world population. This disease …

Toxoplasma gondii is a cosmopolitan protozoan parasite which affects approximately 30%
of the population worldwide. The drugs currently used against toxoplasmosis are few in …

Several treatment failures have been reported for the treatment of toxoplasmic encephalitis,
chorioretinitis, and congenital toxoplasmosis. Recently we found three Toxoplasma gondii …

Abstract Toxoplasmosis in South America presents great health impacts and is a topic of
research interest not only because of the severity of native cases but also due to the …

Toxoplasmosis is a worldwide parasitosis that is generally benign. The infestation may pose
a risk to immunocompromized patients and to fetuses when pregnant women have recently …

Natural resources are recognized as important sources of potential drugs for treating various
infections, and microorganisms are a rich natural source of diverse compounds. Among the …

Toxoplasmosis is a worldwide parasitosis that affects one-third of the population. People at
risk, such as immunocompromised patients (AIDS, chemotherapy treatment) or fetuses …